Literature DB >> 26200484

PIRADS 2.0: what is new?

Baris Turkbey1, Peter L Choyke.   

Abstract

Mesh：

Year:  2015        PMID： 26200484      PMCID： PMC4557320          DOI： 10.5152/dir.2015.15099

Source DB:  PubMed          Journal:  Diagn Interv Radiol        ISSN： 1305-3825            Impact factor:   2.630


× No keyword cloud information.
  11 in total

Review 1.  Local staging of prostate cancer with MRI.

Authors:  Fatma Nur Soylu; Scott Eggener; Aytekin Oto
Journal:  Diagn Interv Radiol       Date:  2012-03-08       Impact factor: 2.630

2.  New data on prostate-cancer mortality after PSA screening.

Authors:  Anthony B Miller
Journal:  N Engl J Med       Date:  2012-03-15       Impact factor: 91.245

3.  Inter-reader agreement of the ESUR score for prostate MRI using in-bore MRI-guided biopsies as the reference standard.

Authors:  L Schimmöller; M Quentin; C Arsov; R S Lanzman; A Hiester; R Rabenalt; G Antoch; P Albers; D Blondin
Journal:  Eur Radiol       Date:  2013-06-12       Impact factor: 5.315

4.  Dynamic Contrast-enhanced MR Imaging Curve-type Analysis: Is It Helpful in the Differentiation of Prostate Cancer from Healthy Peripheral Zone?

Authors:  Barry G Hansford; Yahui Peng; Yulei Jiang; Michael W Vannier; Tatjana Antic; Stephen Thomas; Stephanie McCann; Aytekin Oto
Journal:  Radiology       Date:  2015-01-05       Impact factor: 11.105

5.  Prostate Imaging Reporting and Data System and Likert Scoring System: Multiparametric MR Imaging Validation Study to Screen Patients for Initial Biopsy.

Authors:  Raphaëlle Renard-Penna; Pierre Mozer; François Cornud; Nicolas Barry-Delongchamps; Eric Bruguière; Daniel Portalez; Bernard Malavaud
Journal:  Radiology       Date:  2015-01-19       Impact factor: 11.105

6.  Prostate cancer: value of multiparametric MR imaging at 3 T for detection--histopathologic correlation.

Authors:  Baris Turkbey; Peter A Pinto; Haresh Mani; Marcelino Bernardo; Yuxi Pang; Yolanda L McKinney; Kiranpreet Khurana; Gregory C Ravizzini; Paul S Albert; Maria J Merino; Peter L Choyke
Journal:  Radiology       Date:  2010-04       Impact factor: 11.105

7.  Characterization of prostate lesions as benign or malignant at multiparametric MR imaging: comparison of three scoring systems in patients treated with radical prostatectomy.

Authors:  Tiphaine Vaché; Flavie Bratan; Florence Mège-Lechevallier; Sylvain Roche; Muriel Rabilloud; Olivier Rouvière
Journal:  Radiology       Date:  2014-06-15       Impact factor: 11.105

8.  Evaluation of the PI-RADS scoring system for mpMRI of the prostate: a whole-mount step-section analysis.

Authors:  Daniel Junker; Michael Quentin; Udo Nagele; Michael Edlinger; Jonathan Richenberg; Georg Schaefer; Michael Ladurner; Werner Jaschke; Wolfgang Horninger; Friedrich Aigner
Journal:  World J Urol       Date:  2014-08-01       Impact factor: 4.226

9.  Evaluation of the prostate imaging reporting and data system for the detection of prostate cancer by the results of targeted biopsy of the prostate.

Authors:  Alexander D J Baur; Andreas Maxeiner; Tobias Franiel; Ergin Kilic; Alexander Huppertz; Carsten Schwenke; Bernd Hamm; Tahir Durmus
Journal:  Invest Radiol       Date:  2014-06       Impact factor: 6.016

10.  ESUR prostate MR guidelines 2012.

Authors:  Jelle O Barentsz; Jonathan Richenberg; Richard Clements; Peter Choyke; Sadhna Verma; Geert Villeirs; Olivier Rouviere; Vibeke Logager; Jurgen J Fütterer
Journal:  Eur Radiol       Date:  2012-02-10       Impact factor: 5.315
View more
  24 in total

Review 1.  Screening and Detection of Prostate Cancer-Review of Literature and Current Perspective.

Authors:  Ananthakrishnan Sivaraman; Kulthe Ramesh Seetharam Bhat
Journal:  Indian J Surg Oncol       Date:  2017-01-23

2.  Quantitative characterisation of clinically significant intra-prostatic cancer by prostate-specific membrane antigen (PSMA) expression and cell density on PSMA-11.

Authors:  Liran Domachevsky; Natalia Goldberg; Hanna Bernstine; Meital Nidam; David Groshar
Journal:  Eur Radiol       Date:  2018-05-30       Impact factor: 5.315

3.  Biparametric MRI: a further improvement to PIRADS 2.0?

Authors:  Michele Scialpi; Giuseppe Falcone; Pietro Scialpi; Alfredo D'Andrea
Journal:  Diagn Interv Radiol       Date:  2016 May-Jun       Impact factor: 2.630

4.  Contrast-ing opinions: biparametric versus multiparametric prostate MRI.

Authors:  Tristan Barrett
Journal:  Diagn Interv Radiol       Date:  2016 May-Jun       Impact factor: 2.630

Review 5.  PI-RADS v2: Current standing and future outlook.

Authors:  Clayton P Smith; Barış Türkbey
Journal:  Turk J Urol       Date:  2018-05-01

6.  Evaluating the size criterion for PI-RADSv2 category 5 upgrade: is 15 mm the best threshold?

Authors:  Julie Y An; Stephanie A Harmon; Sherif Mehralivand; Marcin Czarniecki; Clayton P Smith; Julie A Peretti; Bradford J Wood; Peter A Pinto; Peter L Choyke; Joanna H Shih; Baris Turkbey
Journal:  Abdom Radiol (NY)       Date:  2018-12

7.  Prostate cancer: Birth of a standard: MET-RADS-P for metastatic prostate cancer.

Authors:  Baris Turkbey; Peter L Choyke
Journal:  Nat Rev Urol       Date:  2016-08-31       Impact factor: 14.432

Review 8.  Restriction spectrum imaging: An evolving imaging biomarker in prostate MRI.

Authors:  Ryan L Brunsing; Natalie M Schenker-Ahmed; Nathan S White; J Kellogg Parsons; Christopher Kane; Joshua Kuperman; Hauke Bartsch; Andrew Karim Kader; Rebecca Rakow-Penner; Tyler M Seibert; Daniel Margolis; Steven S Raman; Carrie R McDonald; Nikdokht Farid; Santosh Kesari; Donna Hansel; Ahmed Shabaik; Anders M Dale; David S Karow
Journal:  J Magn Reson Imaging       Date:  2016-08-16       Impact factor: 4.813

9.  Comparison of micro-ultrasound and multiparametric magnetic resonance imaging for prostate cancer: A multicenter, prospective analysis.

Authors:  Laurence Klotz; Giovanni Lughezzani; Davide Maffei; Andrea Sánchez; José Gregorio Pereira; Frédéric Staerman; Hannes Cash; Ferdinand Luger; Laurent Lopez; Rafael Sanchez-Salas; Rob Abouassaly; Neal D Shore; Gregg Eure; Marco Paciotti; Ander Astobieta; Laura Wiemer; Sebastian Hofbauer; Robin Heckmann; Andreas Gusenleitner; Jasmin Kaar; Clemens Mayr; Wolfgang Loidl; Jean Rouffilange; Richard Gaston; Xavier Cathelineau; Eric Klein
Journal:  Can Urol Assoc J       Date:  2021-01       Impact factor: 1.862

10.  T1 and T2 MR fingerprinting measurements of prostate cancer and prostatitis correlate with deep learning-derived estimates of epithelium, lumen, and stromal composition on corresponding whole mount histopathology.

Authors:  Rakesh Shiradkar; Ananya Panda; Patrick Leo; Andrew Janowczyk; Xavier Farre; Nafiseh Janaki; Lin Li; Shivani Pahwa; Amr Mahran; Christina Buzzy; Pingfu Fu; Robin Elliott; Gregory MacLennan; Lee Ponsky; Vikas Gulani; Anant Madabhushi
Journal:  Eur Radiol       Date:  2020-09-02       Impact factor: 5.315
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.